BioCentury
ARTICLE | Clinical News

Cangene regulatory update

June 28, 1993 7:00 AM UTC

Cangene Corp. (TSE:CNJ) Cangene Corp. (TSE:CNJ) received a Notice of Interference from the U.S. Patent and Trademark Office regarding its patent application for Nucleic Acid Sequence-Based Amplificat...